PSYC’s CEO to Moderate Panel at Film Screening for ESPN’s Upcoming Documentary, “Peace of Mind”

PSYC Corporation (OTC Pink Market: PSYC), parent company to Spotlight Media Corporation (“SMC” or the “wholly owned subsidiary”), a multimedia leader positioned at the intersection where all things psychedelics and cannabis converge, is pleased to announce that PSYC CEO, David Flores, will participate in the Penn Psychedelics Collaborative (the “PPC”) film screening event, “Psychedelics & the Road…

Mindset Pharma

Mindset Pharma CEO, James Lanthier, Issues Letter to Shareholders Discussing Expansion of Drug Discovery Efforts into Novel Non-Hallucinogenic Therapeutics

Mindset Pharma Inc. (CSE: MSET / SE: 9DF / OTCQB: MSSTF) today issued a letter to shareholders from James Lanthier, Chief Executive Officer of Mindset. Dear Fellow Shareholders: Mindset saw great progress and achievements at all levels in 2022, as we worked diligently towards our ultimate goals of bringing superior neuropsychiatric medications to patients with unmet needs….

Revive Therapeautics

Revive Therapeutics Provides Update on Psilocybin Clinical Study for Methamphetamine Use Disorder

Revive Therapeutics Ltd. (OTCQB: RVVTF / CSE: RVV / FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to provide an update on the Company’s Phase I/II clinical study (the “Study”) (NCT05322954) evaluating the safety and feasibility of oral psilocybin as a…

Psychedelics, Trip Experiences, and the Potential of AI

Artificial intelligence (AI) is becoming increasingly popular as more applications are found and new technology is introduced widely. There are so many different ways that AI could change our society, but one area is often overlooked: psychedelic research. Psychedelic research has grown substantially in the past few years, but there are still some barriers that…